Santen’s Tapros Mini For Glaucoma And Ocular Hypertension Approved
This article was originally published in PharmAsia News
Executive Summary
Santen Pharmaceuticals received approval for their preservative-free ophthalmic solution Tapros Mini (tafluprost) for the treatment of glaucoma and ocular hypertension.